首页|华蟾素通过抑制谷胱甘肽合成酶表达诱导肝癌细胞发生铁死亡的作用机制研究

华蟾素通过抑制谷胱甘肽合成酶表达诱导肝癌细胞发生铁死亡的作用机制研究

扫码查看
目的 研究华蟾素(cinobufotalin)通过抑制谷胱甘肽合成酶(glutathione synthetase,GSS)表达诱导肝癌细胞发生铁死亡的作用机制。方法 不同浓度华蟾素(0、2、4、6、8 μg·mL-1)分别与铁螯合剂(deferoxamine,DFO)50μmol·L-1或还原型谷胱甘肽(glutathione,GSH)5 mmol·L-1联合处理肝癌细胞48 h,采用CCK-8检测细胞活性。采用活性氧(reactive oxygen species,ROS)、丙二醛(malondialdehyde,MDA)和 GSH 检测试剂 盒检测 华蟾素(8μg·mL-1)干预后肿瘤细胞内ROS、MDA和GSH含量。通过实时荧光定量PCR(QRT-PCR)和Western blotting检测华蟾素处理对肝癌细胞GSS表达的影响。并采用RNA干扰技术探究在肝癌细胞中GSS对GSH含量及肝癌细胞增殖的影响。结果 与单独使用华蟾素相比,铁螯合剂DFO能够部分逆转华蟾素对肝癌细胞的增殖抑制作用。与对照组相比,华蟾素干预组能够增加肿瘤细胞内的ROS和MDA含量,降低GSH含量。同时,研究显示GSH能够部分逆转华蟾素对肝癌细胞的增殖抑制作用。深入机制研究发现,华蟾素能够抑制GSS蛋白表达。RNA干扰实验的结果表明,下调GSS蛋白表达能够降低GSH水平。敲低GSS能够削弱DFO对华蟾素增殖抑制的逆转作用,且敲低GSS能够在一定程度上抑制肝癌细胞的生长,并增强华蟾素的增殖抑制作用。结论 华蟾素能够诱导肝癌细胞发生铁死亡,其机制与干预GSS水平有关。该研究为华蟾素临床应用提供理论基础,并对中药抗肿瘤新药开发起到积极的推动作用。
Study on the mechanism of cinobufotalin in inducing ferroptosis of hepatoma cells by inhibiting the expression
Objective To investigate the mechanism of cinobufotalin in inducing ferroptosis of hepatoma cells by inhib-iting the expression of glutathione synthetase(GSS).Methods Hepatoma cells were treated with different concentrations of cinobufotalin(0,2,4,6,8 μg·mL-1)or in combination with deferoxamine(DFO)50 μmol·L-1,glutathione(GSH)5 mmol·L-1 for 48 h,respectively.CCK-8 was used to detect cell viability.Reactive oxygen species(ROS),malondialdehyde(MDA)and GSH assay kit were used to detect ROS,MDA,and GSH levels in tumor cells after treatment of cinobufotalin(8 µg·mL-1).Quantitative real-time PCR(QRT-PCR)and Western blotting were used to detect the effect of cinobufotalin on GSS expression in hepatoma cells.RNA interference technology was used to explore the effect of GSS on GSH level and proliferation potential of hepatoma cells.Results Compared with cinobufotalin treatment alone,the DFO could partially reverse the inhibitory effect of cinobufotalin on hepatoma cells proliferation.Compared with the control group,the ROS and MDA levels were increased and the GSH level was decreased in cinobufotalin treatment group.At the same time,the study showed that GSH could partially reverse the inhibitory effect of cinobufotalin on the proliferation of hepatoma cells.Further mechanism study showed that cinobufotalin could inhibit the expression of GSS protein.The results of RNA in-terference experiment showed that depletion of GSS could reduce GSH level,knockdown of GSS could impair the reverse effect of DFO on the proliferation inhibition of cinobufotalin,and knockdown of GSS could inhibit the growth of hepatoma cells,and enhance the blocking effects of cinobufotalin on cell proliferation of liver cancer cells.Conclusion Cinobufotalin can induce ferroptosis in hepatoma cells,and the mechanism is related to GSS intervention.This study provides a theoretical basis for the clinical application of cinobufotalin,and plays an active role in promoting the development of anti-tumor drugs in traditional Chinese medicine.

CinobufotalinHepatocellular carcinomaFerroptosisGlutathione synthetase

兀琦、杨静依、陈启梅、王安美、孙艺轩、张加余、杨爱琳

展开 >

滨州医学院药学院,山东 烟台 264003

华蟾素 肝癌 铁死亡 谷胱甘肽合成酶

国家自然科学基金青年基金滨州医学院高层次人才科研启动基金

82204693BY2020KYQD13

2024

药学研究
山东省药品检验所 山东省药学会

药学研究

CSTPCD
影响因子:0.653
ISSN:2095-5375
年,卷(期):2024.43(3)
  • 27